Introduction {#s1}
============

The phenotypic variance cumulatively explained by marker loci found to associate with complex traits in genome-wide association studies (GWAS) is usually much less than the narrow-sense heritability [@pcbi.1002459-Maher1]--[@pcbi.1002459-Eichler1], the ratio of additive genetic variance to total phenotypic variance. Several explanations have been proposed for this unexplained variance, popularly called the missing heritability [@pcbi.1002459-Maher1], including imprecise heritability estimates; insufficient sample size; exclusion of particular types of polymorphisms such as copy number variants and rare SNPs in GWAS; unaccounted epistatic effects; and underestimated effect size of associated SNPs due to incomplete linkage with causal variants [@pcbi.1002459-Makowsky1], [@pcbi.1002459-Eichler1]. Recently it was shown [@pcbi.1002459-Yang1] that a large proportion of the missing heritability can be accounted for if one estimates the variance explained by all available marker loci together. This suggests that most of the genetic variation underlying complex trait variation is due to marginal effects of many loci that are too small to pass stringent significance tests. Strong support for this interpretation comes from several meta-analyses of genome-wide association data [@pcbi.1002459-Zeggini1]--[@pcbi.1002459-Kato1]. While this insight appears to resolve much of the missing heritability issue as such, it also implies that standard GWAS approaches will not be very helpful for disclosing which genetic variants do actually contribute to additive variance.

Part of the problem underlying the missing heritability is that while the genotype-phenotype map in reality arises from complex biological systems best described by nonlinear dynamic models, the statistical machinery of quantitative genetics, including GWAS methods, is built upon linear models of gene action. The aim of this study is not to improve the statistical methods *per se*, but rather to explore how more of the missing heritability can be explained and understood by combining nonlinear dynamic models with existing GWAS methods. The research program of linking system dynamics and genetics was suggested more than 40 years ago [@pcbi.1002459-Burns1] and has been an active research area for more than 10 years [@pcbi.1002459-Frank1]--[@pcbi.1002459-Vik1]. Emergent properties of nonlinear systems, such as systemic silencing [@pcbi.1002459-Gjuvsland2], might lead to a situation where genetic variation that penetrates to low-level phenotypes underlying a higher-level phenotype does not necessarily manifest in the higher-level phenotype itself. Doing GWAS on these low-phenotypes may thus reveal more of the genetic variation influencing the higher-level trait. This line of reasoning is reflected in recent GWA studies on metabolite profiles [@pcbi.1002459-Gieger1], [@pcbi.1002459-Illig1], in pathway and network-based analysis of genome-wide association studies [@pcbi.1002459-Baranzini1] and in GWAS analyses on global gene expression data [@pcbi.1002459-Cookson1]--[@pcbi.1002459-AlaKorpela1]. While all these studies represent important contributions, they do not combine a genetic mapping framework with mathematical models describing how high-level trait variation emerges from low-level trait variation, i.e. they do not provide a quantitative framework for elucidating how genetic variation affecting a low-level phenotype do actually influence a focal high-level phenotype.

If a dynamic model can describe the phenotypic variation of a given trait, it follows that irrespective of the biological resolution of the model, the genetic variation underlying the phenotypic variation will have to be reflected as variation in the parameters of the model. We therefore hypothesized that performing GWAS on parameters in computational physiology models might reveal much more of the underlying genetic variation, as well as shedding light on how this variation actually causes phenotypic variation.

To test the plausibility of this reasoning, we combined GWAS methodology with a causally-cohesive genotype-phenotype (cGP) model linking genetic variation to phenotypic variation. More specifically, a cGP model [@pcbi.1002459-Rajasingh1] is a mathematical model of a biological system where low-level parameters have an articulated relationship to an individual\'s genotype, and higher-level phenotypes emerge from the mathematical model describing the causal dynamic relationships between these lower-level processes. Our approach bears some resemblance to that of functional GWAS (fGWAS) [@pcbi.1002459-Das1], where the genetic control of traits is analyzed by integrating biological principles of trait formation into the GWAS framework through mathematical and statistical bridges. Fu *et al.* [@pcbi.1002459-Fu1] recently extended the functional mapping framework [@pcbi.1002459-Ma1] to handle cyclic phenotypes such as circadian rhythms by combining differential equations with functional mapping of QTLs. However, there are clear differences between functional mapping and the cGP approach. In functional mapping the phenotypic measurements are currently done at the systems level, while lower-level parameters are estimated by combining curve-fitting with more classical QTL methods. In contrast, the cGP approach advocated here focuses on measuring lower-level parameters based on the idea that they are highly relevant phenotypes of the system.

We studied a cGP model of a mouse heart cell [@pcbi.1002459-Vik1], where genetic variation is mapped to parametric variation, which propagates through the physiological model to generate multivariate phenotypes for the action potential (an electrical signal) and calcium transient (linked to muscle contraction) under regular pacing. The rationale for using a heart cell model was that multiscale and multiphysics modelling of the mammalian heart has a solid empirical basis, and arguably comprises the most complex mathematical conceptualization of any organ or physiological trait available. For clarity of exposition, and because heart cell models lie at the core of this class of multiscale whole organ models [@pcbi.1002459-Noble1]--[@pcbi.1002459-Smith3], we deemed it sufficient to illustrate our points using a single cell model only. We used HapMap data [@pcbi.1002459-Gibbs1], [@pcbi.1002459-Altshuler1] as a guide to generate genetic variation with realistic allele frequencies and linkage disequilibrium to underlie variation in the model parameters. Based on HapMap [@pcbi.1002459-Altshuler1] individuals we simulated complex pedigree populations and performed GWAS on both low-level parameters and high-level phenotypes arising from the cGP model. The layout of the computational pipeline used for this study is depicted in [Figure 1](#pcbi-1002459-g001){ref-type="fig"}.

![Flowchart of computational pipeline.\
A heart cell model, a genetic map and a virtual population are tied together by selecting heart model parameters assumed to be under influence of genetic variation and associating the parameter variation to a population of virtual genomes based upon HapMap 3 data. Individual genotypes are mapped into heart model parameters (steps 1--3) and by running the heart cell model parameters are mapped into cell-level phenotypes (step 4). Finally, GWAS analysis is then performed on the virtual population (step 5).](pcbi.1002459.g001){#pcbi-1002459-g001}

We show that genome-wide association studies on parameters reveal many more of the underlying SNPs than when using higher-level cellular phenotypes. Furthermore, the SNPs identified by GWAS on parameters can be used to build multivariate prediction models of higher-level phenotypes giving much higher explained variance than from GWAS on higher-level phenotypes alone. Our results suggest that combining statistical genetics with computational biology will facilitate both identification of genetic variation underlying complex traits and a much deeper understanding of how this genetic variation becomes causative.

Methods {#s2}
=======

The general layout of the study is outlined in [Figure 1](#pcbi-1002459-g001){ref-type="fig"}.

Heart cell model {#s2a}
----------------

The cell model [@pcbi.1002459-Li1] extends that of Bondarenko *et al.* [@pcbi.1002459-Bondarenko1] with more realistic calcium handling, conservation of charge, and detailed re-parameterization to consistent experimental data for the C57BL/6 "black 6" mouse. State variables include ion concentrations of sodium, potassium and calcium in the cytosol, calcium concentration in the sarcoplasmic reticulum, and the state distribution of ion channels, whose transition rates between open, closed, and inactivated conformations may depend on transmembrane voltage. Formulated as a system of coupled ordinary differential equations, this model provides a comprehensive representation of membrane-bound channels and transporter functions as well as fluxes between the cytosol and intracellular organelles. As the action potential and calcium transient features following an electrical stimulation are the only state descriptors fed into higher level features of current multiscale heart models [@pcbi.1002459-Smith1], we used these and associated aggregated measures as high-level phenotypes, see "Parameter to phenotype mapping" below. See Vik *et al.* [@pcbi.1002459-Vik1] for a detailed description of this model including model diagram, differential equations and a CellML implementation.

Polymorphic parameters {#s2b}
----------------------

Out of the 86 model parameters we chose 34 to mediate the effects of genetic variation ([Table 1](#pcbi-1002459-t001){ref-type="table"} and [Table S1](#pcbi.1002459.s006){ref-type="supplementary-material"}). Because the genotype to parameter map for parameters describing ion channel properties may in general be much more straightforward than what is the case for many others, we picked mainly parameters describing affinities, conductivities and ion permeabilities for the ion channels and pumps underlying four potassium outward currents, one calcium current, one chloride current, one sodium current, the sodium-calcium exchangers, the sarcoplasmic reticular calcium ATPase (SERCA), the sodium potassium pump, cytosolic calmodulin, the ryanodine receptors on sarcoplasmic reticulum and the calcium handling processes within sarcoplasmic reticulum.

10.1371/journal.pcbi.1002459.t001

###### Parameters with genetic variation.

![](pcbi.1002459.t001){#pcbi-1002459-t001-1}

  Parameter name                                           Description                                             Unit      Baseline value     Min       Max
  ---------------- -------------------------------------------------------------------------------------------- ----------- ---------------- --------- ---------
  **Ka+**                             The PC1 -- PO1 rate constant of the Ryanodine receptor                     µM^−4^/ms      6.08e-3       4.09e-3   8.06e-3
  **Ka−**                             The PO1 -- PC1 rate constant of the Ryanodine receptor                      ms^−1^        7.133-2       4.70e-2   9.58e-2
  **Kb+**                             The PO1 -- PO2 rate constant of the Ryanodine receptor                     µM^−3^/ms      4.05e-3       2.64e-3   5.47e-3
  **Kb−**                             The PO2 -- PO1 rate constant of the Ryanodine receptor                      ms^−1^        9.65e-1       6.32e-1    1.31
  **Kc+**                             The PO1 -- PC2 rate constant of the Ryanodine receptor                      ms^−1^        9.00e-3       6.09e-3   1.20e-2
  **Kc−**                             The PC2 -- PO1 rate constant of the Ryanodine receptor                      ms^−1^        8.00e-4       5.24e-4   1.07e-3
  **m**                     The Ca^2+^ cooperativity parameter of PO1 -- PO2 of the Ryanodine receptor              \-            3.0          1.99      3.97
  **n**                     The Ca^2+^ cooperativity parameter of PC1 -- PO1 of the Ryanodine receptor              \-            4.0          2.75      5.33
  **P_CaL**                               The permeability of the L-type Ca^2+^ channel                           ms^−1^          2.5          1.62      3.30
  **t_L**           The time constant of the switch between open and close states of the L-type Ca^2+^ channel    ms^−1^          1.5          1.01      1.98
  **tau_L**                        The Inactivation time constant of the L-type Ca^2+^ channel                    ms^−1^         1.15e3       7.82e2    1.52e3
  **phi_L**                 The proportion of closed states in open mode of the L-type Ca^2+^ channel               \-            1.80         1.23      2.43
  **Kup**                                          The SERCA affinity to Ca^2+^                                     µM          4.12e-1       2.93e-1   5.68e-1
  **V1**                             The leak constant of the Network Sarcoplasmic Reticulum                      ms^−1^          4.5          3.05      5.90
  **KCSQN**                                    The Calsequestrin affinity to Ca^2+^                                 µM           6.30e2       4.35e2    8.57e2
  **K_Co**                     The affinities of the Na^+^/Ca^2+^ exchanger to extracellular Ca^2+^                 µM           1.4e3        9.38e2    1.85e3
  **K_Ci**                     The affinities of the Na^+^/Ca^2+^ exchanger to intracellular Ca^2+^                 µM            3.6          2.45      4.93
  **K_No**                     The affinities of the Na^+^/Ca^2+^ exchanger to extracellular Na^+^                  µM           8.80e4       6.06e4    1.20e5
  **K_Ni**                     The affinities of the Na^+^/Ca^2+^ exchanger to intracellular Na^+^                  µM           1.2e4        8.38e3    1.58e4
  **KNai**                          The affinity of the Na^+^/K^+^ pump to intracellular Na^+^                      µM           1.66e4       1.13e4    2.17e4
  **KKo**                           The affinity of the Na^+^/K^+^ pump to extracellular K^+^                       µM           1.5e3        1.04e3    2.08e3
  **KpCa**                           The affinity of the Ca^2+^ pump to intracellular Ca^2+^                        µM          2.89e-1       1.95e-1   3.93e-1
  **Vmax**                             The maximal exchange rate of Na^+^/Ca^2+^ exchanger                         pA/pF          3.94         2.71      5.19
  **Imax**                                  The maximal current of the Na^+^/K^+^ pump                             pA/pF          2.49         1.71      3.58
  **GK1**                           The maximal conductance of the time-dependent K^+^ channel                     ms/µF         3.5e-1       2.39e-1   4.52e-1
  **GKr**                      The maximal conductance of the rapid delayed rectifier K^+^ channel                 ms/µF        1.65e-2       1.11e-2   2.17e-2
  **GKur**            The maximal conductance of the ultrarapidly activating delayed rectifier K^+^ channel        ms/µF        2.50e-1       1.76e-1   3.27e-1
  **KCl**                       The half saturation constant of the Ca^2+^ activated Cl^−^ channel                  µM           1.00e1        6.65     1.36e1
  **GNa**                                  The maximal conductance of the Na^+^ channel                            ms/µF         1.60e1       1.07e1    2.10e1
  **GKtof**              The maximal conductance of the rapidly recovering transient outward K^+^ channel          ms/µF        5.35e-1       3.97e-1   7.11e-1
  **GClCa**                       The maximum conductance of the Ca^2+^ activated Cl^−^ channel                    ms/µF         1.00e1        6.56     1.33e1
  **on_rate**                               The autophosphorylation rate of Calmodulin                            ms^−1^         5.0e-2       3.25e-2   6.56e-2
  **off_rate**                             The dephosphorylation rate of the Calmodulin                           ms^−1^         2.0e-4       1.34e-4   2.67e-4
  **IpCm**                                    The maximal current of the Ca^2+^ pump                               pA/pF        9.55e-2       6.35e-2   1.26e-1

Listing of the 34 parameters where genetic variation was introduced. The descriptions, units and baseline values are taken from the original publication [@pcbi.1002459-Li1]. The minimum and maximum values were obtained from the Monte Carlo simulations.

Virtual genome and virtual population {#s2c}
-------------------------------------

To ensure some realism in the construction of the genetic structure of our *in silico* populations in terms of allele frequencies and LD patterns, we extracted HapMap3 data [@pcbi.1002459-Altshuler1] for 2,000 evenly spaced SNPs (∼5000 nucleotides apart) for each of the first 20 autosomal chromosomes. We extracted genotypes for the 40000 SNPs for the 1301 individuals in the 11 HapMap 3 populations. We then expanded this into a population of 5000 individuals by use of the Python package simuPOP [@pcbi.1002459-Peng1]. The population expansion by simuPOP maintained allele frequencies and LD patterns in accordance with the HapMap 3 data. Mutations were introduced based on a symmetric diallelic mutation model, all recombinations were based on genetic maps estimated from the HapMap data and migrations between the 11 subpopulations were allowed for. The mutation rate, migration rate and number of generations used as input to the simuPOP population expansion were 1e-8, 0.001 and 500, respectively.

Genotype to parameter mapping {#s2d}
-----------------------------

Assuming a purely additive genetic model, 400 causal SNPs were randomly sampled from the virtual genome for each of the 34 parameters selected to mediate genetic variation. The genotype to parameter mapping for each parameter was set up by defining the 5,000×40,000 genotype matrix ***G***, where each element *g~ij~* denoted the genotype of individual *i* at SNP *j* (−1 for the homozygous with the least frequent allele, 0 for the heterozygous and 1 for the homozygous with the most frequent allele). We then constructed for each parameter the 40,000x1 relative effect vector ***E***, where element *e~j~* was sampled from a *Laplace* (0, 0.0035) distribution if the *j*-th SNP was among the 400 parameter-specific causative SNPs, and set to 0 otherwise (the relative effect being defined as the percentage increase or decrease of the baseline parameter value ([Table 1](#pcbi-1002459-t001){ref-type="table"} and [Table S1](#pcbi.1002459.s006){ref-type="supplementary-material"})). The 5000-element vector of parameter values for all individuals was then computed as *p(* ***GE*** *+1)*, where *p* is the baseline value. With this procedure, each of the focal 34 parameters was varied within ∼±35% of its baseline value, and for each causal SNP, the heterozygous individuals were assigned the baseline parameter value ([Table 1](#pcbi-1002459-t001){ref-type="table"} and [Table S1](#pcbi.1002459.s006){ref-type="supplementary-material"}). The ±35% parameter variation range was chosen as a compromise between getting ample genetic signals and avoiding too many physiologically unrealistic phenotypes. We also tested a genetic model with 200 causative SNPs for each parameter, the only difference being that the standard deviation of the *Laplace* distribution was set to 0.0049.

Parameter to phenotype mapping {#s2e}
------------------------------

Cellular phenotypes for individual parameter sets were generated by a virtual experiment of constant pacing as described in Bondarenko *et al.* [@pcbi.1002459-Bondarenko1]. The potassium current was stimulated by −15 V/s for 3 ms at the start of each stimulus interval. Convergence was checked by comparing successive intervals with respect to the initial value of each state variable as well as the integral of its trajectory over that interval. A running history of 10 intervals was kept, and after each interval we checked for a match (within a relative tolerance of 5% for all state variables) against the previous one. This was done for three different pacing rates with stimulus intervals of intervals 100, 200 and 300 ms, respectively. The cell dynamics was categorized as "failure" if it did not converge to non-alternating dynamics within 10 minutes of simulation time. The Python code of the heart cell model was autogenerated from CellML [@pcbi.1002459-Lloyd1], using the code generating service available at the CellML repository ([www.cellml.org](http://www.cellml.org)). The equations were integrated using the CVODE solver [@pcbi.1002459-Cohen1] with a Python wrapper.

Eight scalar phenotypes (see [Table 2](#pcbi-1002459-t002){ref-type="table"} and [Table S2](#pcbi.1002459.s007){ref-type="supplementary-material"}) were extracted from each computed action potential and calcium transient curve: the initial value (apbase and ctbase), the amplitude (apamp and ctamp), the peak value (appeak and ctpeak), the time to peak value (apttp and ctttp), the time to 25%, 50%, 75%, and 90% of the initial base value (apd25, apd50, apd75, apd90 and ctd25, ctd50, ctd75, ctd90).

10.1371/journal.pcbi.1002459.t002

###### Attained cellular phenotype values.

![](pcbi.1002459.t002){#pcbi-1002459-t002-2}

  Phenotypes    Unit   Baseline value     Min        Max
  ------------ ------ ---------------- ---------- ---------
  **apd25**      ms         4.34          4.10      4.56
  **apd50**      ms         5.89          5.33      6.39
  **apd75**      ms        1.11e1         9.28     1.29e1
  **apd90**      ms        1.95e1        1.60e1    2.30e1
  **apamp**      mV        1.18e2        1.14e2    1.23e2
  **apbase**     mV       −8.00e1       −8.0.6e1   −7.93e1
  **appeak**     mV        3.82e1        3.41e1    4.23e1
  **apttp**      ms         3.20          3.03      3.35
  **ctd25**      ms        6.19e1        4.80e1    7.98e1
  **ctd50**      ms        1.05e2        7.98e1    1.37e2
  **ctd75**      ms        1.79e2        1.39e2    2.16e2
  **ctd90**      ms        2.55e2        2.20e2    2.79e2
  **ctamp**      µM        1.4e-1       4.85e-2    2.76e-1
  **ctbase**     µM       8.14e-2       6.12e-2    1.05e-1
  **ctpeak**     µM         0.22        1.15e-1    3.68e-1
  **ctttp**      ms        2.40e1        1.93e1    2.98e1

The phenotypic values resulting from use of the baseline parameter values (see [Table 1](#pcbi-1002459-t001){ref-type="table"}) are listed together with the minimum and maximum values achieved in the Monte Carlo simulations.

Data preparation {#s2f}
----------------

We removed individuals with physiologically unrealistic phenotypes within each of the 100 datasets analyzed. The exclusion criterion was based on the inter-quartile range (IQR); points that were more than twice the IQR above the third quartile or below the first quartile were excluded. Each filtered data set, containing 4000--5000 individuals, was divided into a training set of 2500 individuals and a test set consisting of the remaining individuals. The training data set was used to detect causal SNPs, compute the false positive rate and sensitivity characteristics. The test set was used to estimate the phenotypic variation accounted for by the detected SNPs.

Statistical analysis {#s2g}
--------------------

The same GWAS procedure was used for each parameter and each phenotype. The quantitative trait association analysis was performed with the program PLINK [@pcbi.1002459-Purcell1] on the training data. We used a threshold of 1e-5 on the Bonferroni-corrected p-value from PLINK to determine the set of significant SNPs.

The detected SNP set and associated discovery rates were defined as follows. Let ***S*** *~i~* denote the set of significant SNPs from GWAS on the *i*-th parameter and let ***C*** *~i~* denote the causal SNPs set of the *i*-th parameter. The set of detected SNPs of the *i*-th parameter was then computed as ***D*** *~i~* = ***S*** *~i~*∩***C*** *~i~*, and the discovery rate of *i*-th parameter was computed as *d~i~* = \|***D*** *~i~*\|/\|***C*** *~i~*\|. The union of causal SNP sets for parameters defined the causal SNP set underlying all cellular phenotypes, and the detected SNP set and the discovery rate for each cellular phenotype was computed in the same way as for each parameter. The set of false positive SNPs of the *i*-th parameter or phenotype, ***F*** *~i~*, consists of SNPs in the set of significant SNPs ***S~i~*** that are not in the causal SNPs set ***C*** *~i~* ~.~. The false positive rate of the *i*-th parameter or phenotype was defined as the number of false positive SNPs in ***F*** *~i~* divided by the number of signals in ***S~i~***, \|***F*** *~i~*\|/\|***S~i~***\|.

To quantify explained genetic variance a multiple regression model was constructed by regressing the phenotype or parameter value of the training set on the causal SNPs detected by GWAS (similar to the weighted genomic profile approach in [@pcbi.1002459-Aulchenko1]). Then the phenotypes of test set individuals were predicted using the corresponding fitted models. We measured the explained variation by the R^2^ values from regressing observed values on predicted phenotypic values for the individuals in the test set.

Global sensitivity analysis {#s2h}
---------------------------

We quantified the linear sensitivity [@pcbi.1002459-Saltelli1] of each phenotype to each parameter using linear regression in the training set. For each high-level phenotype and Monte Carlo simulation we used the 2500 simulated phenotypes as response and performed a series of univariate regressions each time with a single parameter as predictor. We measured global sensitivity by the coefficient of determination (R^2^).

Results/Discussion {#s3}
==================

The proportion of true causative SNPs detected by GWAS was as expected substantially higher for the parameters than for the cellular phenotypes ([Figure 2](#pcbi-1002459-g002){ref-type="fig"} and [Figure S2](#pcbi.1002459.s002){ref-type="supplementary-material"} for the 200 SNPs case). Median detection rates of causal SNPs were in the range 3.5%--4% after GWAS directly on parameter values ([Figure 2A](#pcbi-1002459-g002){ref-type="fig"}), and this number dropped to ∼0.05% for GWAS studies on action potential phenotypes and ∼0.02% for calcium transient phenotypes ([Figure 2B](#pcbi-1002459-g002){ref-type="fig"}), and the corresponding figures in the 200 SNPs case were 8--8.5%, ∼0.16% and ∼0.08%. The low overall detection rates were to be expected since we sampled SNP effects from an L-shaped distribution resulting in datasets where a small proportion of the SNPs underlying a given parameter will explain a substantial part of the variation. The main explanation for the decrease in detection rates is that the number of causal SNPs increases 34 times and the relative effects of all causal SNPs decrease, making them harder to pick up. Another, probably less important, phenomenon contributing to lower detection rates at the higher-level phenotypes is that going from parameter level to the system-level phenotype introduces nonlinearities in the SNP effects, and standard GWAS methods pick up only the additive part.

![Percentage of causative SNPs detected by GWAS.\
(**A**) The percentage of 400 causative SNPs (y axis) detected as significant SNPs by GWAS on genetically controlled model parameters (x axis). (**B**) The percentage of all 13600 causative SNPs (y axis) detected as significant SNPs by GWAS on cellular phenotypes (x axis). Each boxplot summarizes 100 Monte Carlo runs. See [Methods](#s2){ref-type="sec"} for further descriptions of model parameters and phenotypes.](pcbi.1002459.g002){#pcbi-1002459-g002}

The difference between parameter and cellular phenotypes is also evident when looking at the amount of phenotypic variance explained by SNPs detected in the GWAS ([Figure 3](#pcbi-1002459-g003){ref-type="fig"} and [Figure S3](#pcbi.1002459.s003){ref-type="supplementary-material"} for the 200 SNPs case). The median explained variance is typically in the range 30--40% for parameter phenotypes ([Figure 3A](#pcbi-1002459-g003){ref-type="fig"}), 10--20% for action potential phenotypes and ∼5% for calcium transient phenotypes ([Figure 3B](#pcbi-1002459-g003){ref-type="fig"}). The proportion of phenotypic variance explained by detected SNPs was on average 2.6 (2.0 in the 200 SNP case) and 5.6 (3.9 for the 200 SNPs case) times higher for a parameter phenotype than for an action potential and calcium transient phenotype, respectively. However, when we made use of the SNPs detected for parameters we were able to explain 1.8 and 3.9 times (1.6 and 2.9 times for the 200 SNPs case) more of the phenotypic variance of the action potential and calcium transient phenotypes, respectively, approaching the levels obtained for the parameters ([Figure 3C](#pcbi-1002459-g003){ref-type="fig"}). We also calculated the explained variances with all significant SNPs and obtained similar results. This suggests that our approach can be tested empirically in a straightforward way.

![Phenotypic variance explained by genotypic variation.\
(**A**) Total explained variance for genetically controlled parameters (x axis) using detected causal SNPs as predictors. (**B**) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from GWAS targeting these phenotypes. (**C**) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from GWAS targeting all genetically controlled parameters. Each boxplot summarizes total explained variance by GWAS for 100 Monte Carlo runs. Explained variance was measured as R^2^ from test set prediction with a multiple regression model, see [Methods](#s2){ref-type="sec"} for further descriptions.](pcbi.1002459.g003){#pcbi-1002459-g003}

The gain in explained variance by using parameter-associated SNPs was not as dramatic for the action potential phenotypes as for the calcium transient phenotypes ([Figure 3C](#pcbi-1002459-g003){ref-type="fig"}), but even in this case the gain in number of identified SNPs was on average 13.9× (12.3 for the 200 SNPs case). The corresponding figure for the calcium transient phenotypes was 39.4× (26.5 for the 200 SNPs case). Because these additional SNPs are attached to one or more parameters describing specific biological processes or features that are causally related according to the functional structure of the mathematical model, the gain in our causal understanding of the genotype to phenotype map may be substantial.

Both the detection rate of causal SNP and the variances explained for the calcium transient phenotypes were overall significantly lower than those for the action potential phenotypes ([Figure 2B](#pcbi-1002459-g002){ref-type="fig"} and [3B](#pcbi-1002459-g003){ref-type="fig"}). We investigated this further by a linear global sensitivity analysis of how variation in the cellular phenotypes depended on variation in the parameters, and compared this with the number of causative SNPs for each parameter detected by performing GWAS on high-level cellular phenotypes. We found that the GWAS results for the two cellular phenotype groups are predominantly a consequence of the sensitivity structure of the dynamic model ([Figure 4](#pcbi-1002459-g004){ref-type="fig"} and [Figure S4](#pcbi.1002459.s004){ref-type="supplementary-material"} for the 200 SNPs case), and that the action potential phenotypes are overall more sensitive to fewer parameters than the calcium transient phenotypes. The only exception to this latter pattern is the parameter Kup, quantifying the affinity of SERCA to calcium ions ([Figure 4A](#pcbi-1002459-g004){ref-type="fig"}). It has a substantial impact on the calcium transient base value phenotype (ctbase), and the amount of variance explained by the SNPs detected for this phenotype is on par with the action potential phenotypes ([Figure 3B](#pcbi-1002459-g003){ref-type="fig"}). This suggests that SNPs associated with traits that are sensitive to few parameters will have a higher penetrance than SNPs associated with traits that are sensitive to many parameters for a given model resolution. Moreover, the results imply that the more poly-parametric the sensitivity profile of a model phenotype is, the more will be gained in terms of added explained variance by performing GWAS on parameters. On the other hand, the results also imply that a sensitivity analysis can be used to systematically reveal hotspots for genetic variation underlying a complex trait and thus guide a parameter phenotyping program. Within this framework a SNP affecting a parameter to which the focal higher-level phenotypes are not very sensitive will have little impact on these phenotypes unless it is highly penetrant at the parameter level.

![The close resemblance between GWAS results and linear sensitivity analysis.\
(**A**) The number of causative SNPs for each parameter(y axis) detected by performing GWAS on high-level cellular phenotypes(x axis). The color intensity of each square describes the mean value of 100 Monte Carlo runs. (**B**) Sensitivities of the high-level phenotypes (x axis) of the 2500 individuals in the training set to variation in each parameter (y axis) quantified by univariate linear regression (see [Methods](#s2){ref-type="sec"}). The color intensity of each square describes the mean R^2^ (coefficient of determination) value of 100 Monte Carlo runs.](pcbi.1002459.g004){#pcbi-1002459-g004}

GWAS methods are well known for producing false positives due to multiple testing and high LD between SNPs. A typical GWAS block of SNPs in high LD is often reduced to a subset of tagSNPs in low LD (typically with a pairwise correlation \<0.2). The GWAS methods are aimed at identifying significant tagSNPs, and the task of distinguishing the causal SNPs from false positives in high LD has to be done with other methods such as functional studies of candidate SNPs. Our approach is not intended to solve this problem (but see e.g. [@pcbi.1002459-Cantor1], [@pcbi.1002459-Ioannidis1] for reviews of methods for identifying causal variants after GWAS) and in our study the increases detection rate for parameters is accompanied by an expected increased false positive rate ([Figure S1](#pcbi.1002459.s001){ref-type="supplementary-material"} and [Figure S5](#pcbi.1002459.s005){ref-type="supplementary-material"} for the 200 SNPs case). However, as parameters as a rule are closer to mechanism than higher-level phenotypes, it should be noted that to do GWAS on parameters could become very instrumental for identifying candidate mechanisms and genes for follow up studies. We envision that ongoing efforts such as the RICORDO project [@pcbi.1002459-deBono1] aimed at developing semantic interoperability for biomedical data and models will facilitate bioinformatic identification of candidate mechanisms and genes from cGP model sensitivities and GWAS results on parameter phenotypes.

We made deliberate use of the simplest possible genotype to parameter map in this study. A more complex map incorporating genetic dominance and various types of epistasis [@pcbi.1002459-Phillips1] would have diminished the SNP discovery rates and the explained variances of the parameters. However, this reduction in penetrance would apply equally well at higher phenotypic levels, and so would not affect our conclusions. We did not put any environmental variation on the parameters as we deemed this unnecessary in a context where the main focus was to compare the genetic signal strength at the parameter and cellular phenotype levels. However, in future studies this aspect needs to be taken into account in order to make quantitative assessments of how well we will be able to pick up genetic signals as function of environmental variation.

Our approach will remain useful in conjunction with future advances in statistical GWAS methodology, as it is applicable to any phenotypic variation that can be described by computational physiological modeling, irrespective of its position in the phenotypic hierarchy. Even in those cases where the parameters of a computational model are quite high-level phenotypes, our results suggest that one will be able to gain insights about the genotype to phenotype map that would otherwise be challenging to achieve.

There has been an enormous expansion in efforts to model complex biological systems the last decade, and steadily expanding model repositories such as <http://www.cellml.org> and <http://biomodels.net> facilitate exchange and reuse of such models. Illustratively, our study benefited from the reuse of a model available in CellML format. Future development of the cGP approach and systems genetics in general will benefit greatly from these standards and online resources as well as modeling efforts like the Virtual Physiological Human (<http://www.vph-noe.eu>).

Reflecting upon how to improve the current performance of large-scale GWA studies aiming to find the genetic determinants underlying complex diseases, Dermitzakis and Clark stated recently that "A major breakthrough will be to predict and interpret the effect of mutational and biochemical changes in human cells and understand how this signal is transmitted spatially (among tissues) and temporally (spanning development)" [@pcbi.1002459-Dermitzakis1]. Our results suggest that combining GWAS methodology with a mature phenomics technology guided to fit the needs of computational physiology [@pcbi.1002459-Houle1], may contribute substantially to making this vision come true.

Supporting Information {#s4}
======================

###### 

**False positive rates of GWAS on parameters and cellular phenotypes (400 SNPs case).** Boxplots summarizing false positive rates (y axis) for 100 Monte Carlo simulations for (**A**) parameters and (**B**) cellular phenotypes. The false positive rate is defined as the proportion of the non-causative SNPs among those identified as significant by the GWAS.

(EPS)

###### 

Click here for additional data file.

###### 

**Percentage of causative SNPs detected by GWAS (200 SNPs case).** (**A**) The percentage of 200 causative SNPs (y axis) detected as significant SNPs by GWAS on genetically controlled model parameters (x axis). (**B**) The percentage of all 6800 causative SNPs (y axis) detected as significant SNPs by GWAS on cellular phenotypes (x axis). Each boxplot summarizes 100 Monte Carlo runs. See [Methods](#s2){ref-type="sec"} for further descriptions of model parameters and phenotypes.

(EPS)

###### 

Click here for additional data file.

###### 

**Phenotypic variance explained by genotypic variation (200 SNPs case).** (**A**) Total explained variance for genetically controlled parameters (x axis) using detected causal SNPs as predictors. (**B**) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from GWAS targeting these phenotypes. (**C**) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from GWAS targeting all genetically controlled parameters. Each boxplot summarizes total explained variance by GWAS for 100 Monte Carlo runs. Explained variance was measured as R^2^ from test set prediction with a multiple regression model, see [Methods](#s2){ref-type="sec"} for further descriptions.
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Click here for additional data file.

###### 

**The close resemblance between GWAS results and linear sensitivity analysis (200 SNPs case).** (**A**) The number of causative SNPs for each parameter (y axis) detected by performing GWAS on high-level cellular phenotypes (x axis). The color intensity of each square describes the mean value of 100 Monte Carlo runs. (**B**) Sensitivities of the high-level phenotypes (x axis) of the 2500 individuals in the training set to variation in each parameter (y axis) quantified by univariate linear regression (see [Methods](#s2){ref-type="sec"}). The color intensity of each square describes the mean R^2^ (coefficient of determination) value of 100 Monte Carlo runs.
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Click here for additional data file.

###### 

**False positive rates of GWAS on parameters and cellular phenotypes (200 SNPs case).** Boxplots summarizing false positive rates (y axis) for 100 Monte Carlo simulations for (**A**) parameters and (**B**) cellular phenotypes. The false positive rate is defined as the proportion of the non-causative SNPs among those identified as significant by the GWAS.
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Click here for additional data file.

###### 

**Parameters with genetic variation.** This supplementary table contains data similar to that shown in [Table 1](#pcbi-1002459-t001){ref-type="table"}, the only difference being that it is based on 200 causal SNPs per parameter instead of 400.

(PDF)

###### 

Click here for additional data file.

###### 

**Attained cellular phenotype values.** This supplementary table contains data similar to that shown in [Table 2](#pcbi-1002459-t002){ref-type="table"}, the only difference being that it is based on 200 causal SNPs per parameter instead of 400.

(PDF)

###### 

Click here for additional data file.
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